Challenges in circulating tumour cell research
By C. Alix‐Panabières, K. Pantel. Nature Reviews. Cancer, 2014
1,227 citations recorded by the source corpus.
Subfields: Cancer Research, Oncology
View Paper: https://www.semanticscholar.org/paper/43d23a437ab484701febf54c1155dd8a8694a54b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Oncology
Citations in the corpus
- Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis (2015, background): “Notch signaling can induce EMT and maintain stemness (170); however, our understanding of the different roles of the two sub-families of ligands (Delta and Jagged) of Notch signaling is only recent (171–173), and incomplete in the context of EMT and/or CSCs. Notwithstanding this lack of knowledge, J”
- Revisiting the hallmarks of cancer. (2017, neutral): “Multiple challenges still stand in the way and will need to be addressed before clinical utilization [128].”
- Genetics and biology of prostate cancer (2018, background): “The second strategy takes advantage of liquid biopsy technology to identify biomarkers involving CTCs, cell-free tumor DNA, microRNAs, and microvesicles isolated from the blood, urine, saliva, pleural effusions, and cerebrospinal fluid (Alix-Panabieres et al. 2012; Alix-Panabieres and Pantel 2014; H”
- Liquid Biopsy: From Discovery to Clinical Application. (2021, methodology): “After enrichment, an identification step is required to detect CTCs surrounded by the remaining leukocytes at the single-cell level using immunologic, molecular, or functional assays (24).”
- RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics (2015, neutral): “So far, none of the current blood-based biosources, including plasma DNA, exosomes, and CTCs, have been employed for multiclass cancer diagnostics (Alix-Panabières and Pantel, 2014; Bettegowda et al., 2014; Skog et al., 2008), hampering its implementation for early cancer detection.”